Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
With the slowdown in world economic growth, the Professional Diagnostics industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Professional Diagnostics market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2019, Stratagem Market Insights analysts believe that in the next few years, Professional Diagnostics market size will be further expanded, we expect that by 2026, The market size of the Professional Diagnostics will reach XXX million $.
Professional diagnostics approaches offer rapid detection of diseases such as cancer, diabetes, and several infectious diseases. Increasing prevalence of cancer is expected to boost growth of the global professional diagnostics market over the forecast period. For instance, according to the World Health Organization, around 18.1 million new cases and 9.6 million deaths were registered due to cancer worldwide in 2018. Moreover, increasing demand for point-of-care testing (POCT) is also expected to aid in growth of the market. POCT offers various advantages such as reduced number of clinic visits, reduced length of hospital stay, optimized drug treatment, and reduced use of blood products.
High incidence of infectious diseases is expected to propel growth of the global professional diagnostics market over the forecast period. For instance, according to the study, ‘National Burden of Candidemia, United States, 2017, published in November 2018, in the journal Open Forum Infectious Diseases, invasive candidiasis (candidemia) is one of the most common bloodstream infections in the U.S. and the average incidence for the disease was around 9 per 100,000 people during 2013–2017. Moreover, high prevalence of life-threatening conditions such as sepsis is also expected to aid in growth of the market. For instance, according to a report published in NEJM Journal Watch in January 2019, the incidence of sepsis in the U.S. increased annually by 8% to 9% during the 2000-2016.
Increasing geriatric population is expected to offer lucrative growth opportunities for players in the global professional diagnostics market over the forecast period. For instance, according to the World Health Organization, geriatric population is expected to reach 2 billion by 2050, up from 900 million in 2015. Moreover, rapid developments in laboratory automation is also expected to aid in growth of the market. For instance, in February 2020, COPAN Diagnostics, Inc. launched Radian, a new system for fully automatic Kirby-Bauer susceptibility testing.
The market is witnessing increasing adoption of molecular diagnostic tests. For instance, in February 2020, The Foundation for Innovative New Diagnostics (FIND) collaborated with the World Health Organization to perform a standardized evaluation of currently available molecular diagnostic tests in the diagnosis of SARS-CoV-2.
Major players in the market are focused on launching new products to expand their product portfolio. For instance, in January 2020, Veredus Laboratories, a provider of molecular diagnostic solutions, announced the development of VereCoV detection kit, a portable Lab-on-Chip application capable of detecting the Middle-East Respiratory Syndrome Coronavirus (MERS-CoV), Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), and 2019 Novel Coronavirus (2019-nCoV).
Key Takeaways:
- Increasing prevalence of cancer TO AUGMENT growth of the global professional diagnostics market over the forecast period
- The market is witnessing increasing adoption of molecular diagnostic tests
- Major players operating in the global professional diagnostics market include, Abbott Diagnostics, Danaher, Roche Diagnostics, Siemens Healthcare, Thermo Fisher Scientific, A&T Corporation, Menarini Diagnostics, Abaxis, Abcam, Accriva Diagnostics, Acon Laboratories, and Affymetrix
This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.
Section 1: Definition
Section (2 3): Manufacturer Detail
✦ Abbott Diagnostics
✦ Danaher
✦ Roche Diagnostics
✦ Siemens Healthcare
✦ Thermo Fisher Scientific
✦ A&T Corporation
✦ Menarini Diagnostics
✦ Abaxis
✦ Abcam
✦ Accriva Diagnostics
✦ Acon Laboratories
✦ Affymetrix
Section 4: Region Segmentation
✦ North America Country (United States, Canada)
✦ South America
✦ Asia Country (China, Japan, India, Korea)
✦ Europe Country (Germany, UK, France, Italy)
✦ Other Country (Middle East, Africa, GCC)
Section (5 6 7): Type Segmentation
Product Type Segmentation ✑
✦ Immunochemistry
✦ Clinical Microbiology
✦ POCT
✦ Hematology
✦ Hemostasis
Industry Segmentation ✑
✦ Hospitals
✦ Diagnostic Laboratories
Channel (Direct Sales, Distributor) Segmentation
Section 8: Trend (2019-2026)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion
